X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (38) 38
humans (37) 37
female (33) 33
male (30) 30
middle aged (21) 21
aged (18) 18
risk factors (14) 14
atrial fibrillation (13) 13
cardiac & cardiovascular systems (13) 13
stroke (13) 13
adult (11) 11
neurosciences (11) 11
dopamine (10) 10
treatment outcome (10) 10
abridged index medicus (9) 9
care and treatment (9) 9
prospective studies (9) 9
young adult (9) 9
adolescent (8) 8
management (8) 8
medicine and health sciences (7) 7
patients (7) 7
psychiatry (7) 7
research (7) 7
aged, 80 and over (6) 6
animals (6) 6
anticoagulants (6) 6
atrial fibrillation - drug therapy (6) 6
basal ganglia (6) 6
biology and life sciences (6) 6
cognition (6) 6
guidelines (6) 6
hemorrhage (6) 6
medical and health sciences (6) 6
medicin och hälsovetenskap (6) 6
patient outcomes (6) 6
pharmacology & pharmacy (6) 6
prefrontal cortex (6) 6
studies (6) 6
time factors (6) 6
acute coronary syndrome - drug therapy (5) 5
acute coronary syndromes (5) 5
anticoagulation (5) 5
article (5) 5
cardiac and cardiovascular systems (5) 5
clinical medicine (5) 5
health aspects (5) 5
heart attacks (5) 5
kardiologi (5) 5
klinisk medicin (5) 5
mortality (5) 5
myocardial-infarction (5) 5
nucleus-accumbens (5) 5
pharmacology (5) 5
prevention (5) 5
registries (5) 5
research article (5) 5
reward (5) 5
risk (5) 5
serotonin (5) 5
stroke - prevention & control (5) 5
therapy (5) 5
warfarin (5) 5
women (5) 5
acute coronary syndrome (4) 4
angina pectoris (4) 4
anticoagulants - adverse effects (4) 4
anticoagulants - therapeutic use (4) 4
brain (4) 4
cancer (4) 4
cardiovascular (4) 4
child (4) 4
diagnosis (4) 4
double-blind method (4) 4
fmri (4) 4
follow-up studies (4) 4
genetic aspects (4) 4
genetics & heredity (4) 4
hemorrhage - chemically induced (4) 4
magnetic resonance imaging (4) 4
parkinson disease - physiopathology (4) 4
parkinson's disease (4) 4
psychopharmacology (4) 4
risk assessment (4) 4
sex factors (4) 4
stroke prevention (4) 4
usage (4) 4
acute lymphocytic leukemia (3) 3
adenosine - analogs & derivatives (3) 3
adenosine - therapeutic use (3) 3
administration, oral (3) 3
antiplatelet therapy (3) 3
atrial fibrillation - diagnosis (3) 3
atrial fibrillation - epidemiology (3) 3
atrial fibrillation - mortality (3) 3
behavior (3) 3
biomedicine (3) 3
bleeding (3) 3
cardiac patients (3) 3
cardiovascular disease (3) 3
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


American Journal of Cardiology, The, ISSN 0002-9149, 2011, Volume 108, Issue 11, pp. 1542 - 1546
Journal Article
American Heart Journal, ISSN 0002-8703, 2014, Volume 168, Issue 1, pp. 68 - 75.e2
Journal Article
American Heart Journal, ISSN 0002-8703, 2013, Volume 166, Issue 3, pp. 474 - 480
Journal Article
Heart, ISSN 1355-6037, 02/2017, Volume 103, Issue 4, pp. 307 - 314
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 10/2013, Volume 369, Issue 14, pp. 1327 - 1335
Alogliptin, a new antihyperglycemic agent of the DPP-4 class, was shown to have no significant effect on cardiovascular risk over a median treatment period of... 
INHIBITOR ALOGLIPTIN | MEDICINE, GENERAL & INTERNAL | CARDIOVASCULAR SAFETY | MELLITUS | OUTCOMES | MYOCARDIAL-INFARCTION | Hypoglycemic Agents - therapeutic use | Double-Blind Method | Dipeptidyl-Peptidase IV Inhibitors - adverse effects | Dipeptidyl-Peptidase IV Inhibitors - therapeutic use | Glycated Hemoglobin A - metabolism | Humans | Middle Aged | Uracil - therapeutic use | Male | Myocardial Infarction - complications | Myocardial Infarction - drug therapy | Uracil - adverse effects | Angina, Unstable - drug therapy | Piperidines - therapeutic use | Angina, Unstable - complications | Piperidines - adverse effects | Cardiovascular Diseases - mortality | Female | Aged | Diabetes Mellitus, Type 2 - drug therapy | Hypoglycemic Agents - adverse effects | Diabetes Mellitus, Type 2 - complications | Uracil - analogs & derivatives | Type 2 diabetes | Care and treatment | Acute coronary syndrome | Patient outcomes | Risk factors | Myocardial infarction | Heart attacks | Cardiovascular disease | Angina | Drug development | Hemoglobin | Diabetes mellitus (non-insulin dependent) | Drug dosages | Cerebral infarction | Stroke | Peptidase | Statistical analysis | Diabetes mellitus | Pancreatitis | Committees | FDA approval | Hypoglycemia | Angina pectoris | Studies | Product development | Diabetes | Acute coronary syndromes | Cardiovascular diseases | Health risk assessment | Cancer
Journal Article
European Heart Journal, ISSN 0195-668X, 10/2016, Volume 37, Issue 38, pp. 2882 - 2889A
The relationship between outcomes and time after diagnosis for patients with non-valvular atrial fibrillation (NVAF) is poorly defined, especially beyond the... 
Stroke prevention | Stroke | Anticoagulation | Atrial fibrillation | Bleeding | MORTALITY | CARDIAC & CARDIOVASCULAR SYSTEMS | HEART-FAILURE | PREVENTION | DEATH | PREVALENCE | RISK STRATIFICATION SCHEMES | ANTITHROMBOTIC TREATMENT | RHYTHM MANAGEMENT | REGISTRY | Clinical Research
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 11/2018, Volume 379, Issue 22, pp. 2097 - 2107
Among patients who had had an acute coronary syndrome, the risk of death from coronary heart disease, nonfatal myocardial infarction, stroke, or unstable... 
MEDICINE, GENERAL & INTERNAL | MANAGEMENT | MYOCARDIAL-INFARCTION | TASK-FORCE | EFFICACY | SAFETY | LDL | REDUCING LIPIDS | PCSK9 | MONOCLONAL-ANTIBODY | ASSOCIATION | Double-Blind Method | Follow-Up Studies | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Antibodies, Monoclonal - adverse effects | Antibodies, Monoclonal - therapeutic use | Male | Hypercholesterolemia - drug therapy | Anticholesteremic Agents - adverse effects | Acute Coronary Syndrome - blood | Acute Coronary Syndrome - drug therapy | Acute Coronary Syndrome - complications | Anticholesteremic Agents - therapeutic use | Proprotein Convertase 9 - antagonists & inhibitors | Cardiovascular Diseases - epidemiology | Adult | Cholesterol, LDL - blood | Female | Hypercholesterolemia - complications | Aged | Acute coronary syndrome | Diagnosis | Myocardial infarction | Fees & charges | Lipoproteins (low density) | Heart attacks | Lipids | Cardiovascular disease | Angina | Apolipoprotein B | Ischemia | Heart diseases | Drug dosages | Statins | Cerebral infarction | Stroke | Subtilisin | Angina pectoris | Patients | Low density lipoprotein | Coronary artery disease | Cholesterol | Kexin | Monoclonal antibodies | Full text | Acute coronary syndromes | Cardiovascular diseases | Health risk assessment | Pharmaceuticals | Life Sciences | Human health and pathology | Cardiology and cardiovascular system | Kardiologi | Clinical Medicine | Cardiac and Cardiovascular Systems | Medical and Health Sciences | Klinisk medicin | Medicin och hälsovetenskap
Journal Article